0001104659-24-024981.txt : 20240216 0001104659-24-024981.hdr.sgml : 20240216 20240216165845 ACCESSION NUMBER: 0001104659-24-024981 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PFREUNDSCHUH PETER P. CENTRAL INDEX KEY: 0001585839 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37625 FILM NUMBER: 24649234 MAIL ADDRESS: STREET 1: C/O IMMUNOMEDICS, INC. STREET 2: 300 THE AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Voyager Therapeutics, Inc. CENTRAL INDEX KEY: 0001640266 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-259-5340 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 tm246517-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-09 0 0001640266 Voyager Therapeutics, Inc. VYGR 0001585839 PFREUNDSCHUH PETER P. C/O VOYAGER THERAPEUTICS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-02-09 4 A 0 30000 0 A 179433 D Stock Option (Right to Buy) 7.60 2024-02-09 4 A 0 60000 0 A 2034-02-09 Common Stock 60000 60000 D Consists of shares of common stock issuable under an aggregate of 30,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service. This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service. /s/ Scott MacDonald, as Attorney-in-Fact for Peter P. Pfreundschuh 2024-02-16